These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 20581102

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway.
    Tyagi N, Gillespie W, Vacek JC, Sen U, Tyagi SC, Lominadze D.
    J Cell Physiol; 2009 Jul; 220(1):257-66. PubMed ID: 19308943
    [Abstract] [Full Text] [Related]

  • 6. Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery.
    Kumar M, Tyagi N, Moshal KS, Sen U, Kundu S, Mishra PK, Givvimani S, Tyagi SC.
    Neurochem Int; 2008 Dec; 53(6-8):214-9. PubMed ID: 18725259
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice.
    Ovechkin AV, Tyagi N, Sen U, Lominadze D, Steed MM, Moshal KS, Tyagi SC.
    Am J Physiol Lung Cell Mol Physiol; 2006 Nov; 291(5):L905-11. PubMed ID: 16815886
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Oxidative remodeling in pressure overload induced chronic heart failure.
    Henderson BC, Tyagi N, Ovechkin A, Kartha GK, Moshal KS, Tyagi SC.
    Eur J Heart Fail; 2007 May; 9(5):450-7. PubMed ID: 17306621
    [Abstract] [Full Text] [Related]

  • 12. Epigenetic regulation of aortic remodeling in hyperhomocysteinemia.
    Narayanan N, Pushpakumar SB, Givvimani S, Kundu S, Metreveli N, James D, Bratcher AP, Tyagi SC.
    FASEB J; 2014 Aug; 28(8):3411-22. PubMed ID: 24739303
    [Abstract] [Full Text] [Related]

  • 13. Chronic hyperhomocysteinemia causes vascular remodelling by instigating vein phenotype in artery.
    Basu P, Qipshidze N, Sen U, Givvimani S, Munjal C, Mishra PK, Tyagi SC.
    Arch Physiol Biochem; 2011 Dec; 117(5):270-82. PubMed ID: 21838575
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via μ-calpain activation.
    Cheng Z, Jiang X, Pansuria M, Fang P, Mai J, Mallilankaraman K, Gandhirajan RK, Eguchi S, Scalia R, Madesh M, Yang X, Wang H.
    Diabetes; 2015 Mar; 64(3):947-59. PubMed ID: 25352635
    [Abstract] [Full Text] [Related]

  • 17. Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.
    Theodorakis NG, Wang YN, Korshunov VA, Maluccio MA, Skill NJ.
    World J Gastroenterol; 2015 Apr 14; 21(14):4126-35. PubMed ID: 25892862
    [Abstract] [Full Text] [Related]

  • 18. Nitric oxide synthases modulate progenitor and resident endothelial cell behavior in galactosemia.
    Ellis EA, Sengupta N, Caballero S, Guthrie SM, Mames RN, Grant MB.
    Antioxid Redox Signal; 2005 Apr 14; 7(11-12):1413-22. PubMed ID: 16356104
    [Abstract] [Full Text] [Related]

  • 19. Cystathionine beta synthase gene dose dependent vascular remodeling in murine model of hyperhomocysteinemia.
    Tyagi N, Qipshidze N, Sen U, Rodriguez W, Ovechkin A, Tyagi SC.
    Int J Physiol Pathophysiol Pharmacol; 2011 Sep 30; 3(3):210-22. PubMed ID: 21941612
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.